Vault-13

BRIDGEBIO ONCOLOGY THERAPEUT BBOT

COM NEW · Common Stock · CUSIP 107924102

53 institutional holders +11 vs Q3 2025
58,307,76058.3m shares reported held*
$756.1mreported value*
15 new 12 added 12 reduced 4 sold out net bought ≈ $18.7m (+1.5m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $12.97.

Trends to Q4 2025

Institutional holders

Managers reporting a position, each quarter

0204060Q3 25: 42Q4 25: 5353Q3 25Q4 25
Numbers
QuarterHolders
Q3 202542
Q4 202553

Biggest buyers

ARMISTICE CAPITAL, LLC Added +588,000+588.0k
Laurion Capital Management LP Added +419,138+419.1k
Catalio Capital Management, LP New +410,700+410.7k
Paradigm Biocapital Advisors LP Added +395,608+395.6k
HighVista Strategies LLC New +229,263+229.3k
VANGUARD GROUP INC Added +143,496+143.5k
GOLDMAN SACHS GROUP INC New +94,651+94.7k
FMR LLC Added +78,223+78.2k
RENAISSANCE TECHNOLOGIES LLC New +74,300+74.3k
MANUFACTURERS LIFE INSURANCE COMPANY, THE New +54,192+54.2k

Biggest sellers

SILVERARC CAPITAL MANAGEMENT, LLC Sold out -457,414-457.4k
ADAR1 Capital Management, LLC Reduced -274,980-275.0k
MILLENNIUM MANAGEMENT LLC Reduced -128,148-128.1k
STEMPOINT CAPITAL LP Reduced -100,097-100.1k
ADAGE CAPITAL PARTNERS GP, L.L.C. Reduced -87,621-87.6k
PRICE T ROWE ASSOCIATES INC /MD/ Reduced -81,908-81.9k
WELLINGTON MANAGEMENT GROUP LLP Reduced -54,260-54.3k
NORTHERN TRUST CORP Reduced -37,923-37.9k
BOOTHBAY FUND MANAGEMENT, LLC Reduced -29,517-29.5k
Ikarian Capital, LLC Reduced -25,000-25.0k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Helix Holdings II LLC 13D · may seek influence filed 2025-08-13
Stated purposeItem 4 is hereby amended and supplemented as follows: As previously disclosed, on February 28, 2025, the Issuer (which was formerly known as Helix Acquisition Corp. II, "Helix") entered into a Business Combination Agreement (as amended on June 20, 2025, the "Business Combination Agreement") with TheRas, Inc. (d/b/a BridgeBio Oncology Therapeutics, "Legacy BBOT"), and Helix II Merger Sub, Inc. ("Merger Sub"), pursuant to which, subject to the satisfaction or waiver of certain conditions set forth therein, the Domestication of Helix as a Delaware corporation would occur, followed by the Merger of Merger Sub with and into Legacy BBOT. Prior to the Business Combination, Ms. Chen was the Chairwoman and Chief Executive Officer of the Issuer, a shareholder of the Issuer, and a shareholder of Leg… Full filing
22.6% 17.9m≈ $136.2m 2025-08-13
Chen Bihua 13D · may seek influence filed 2026-07-06
Stated purposeItem 4 is hereby amended and supplemented as follows: On July 1, 2026, Sponsor distributed 4,528,186 shares of Common Stock, pro rata, to its members for no consideration. Following such transaction, Sponsor holds no shares of Common Stock. As a result of Sponsor's pro rata distribution of shares to its members, (i) Fund III, a member of Sponsor, acquired 2,692,459 shares of Common Stock; (ii) Fund V, a member of Sponsor, acquired 1,704,862 shares of Common Stock; and (iii) Master Fund, a member of Sponsor, acquired 130,865 shares of Common Stock. Full filing
22.3% 17.9m≈ $136.2m 2026-07-06
BridgeBio Pharma LLC 13D · may seek influence new · filed 2025-08-18
Stated purposeThe Reporting Persons acquired the Shares for investment purposes in the ordinary course of business. Immediately following the Effective Time of the Business Combination, Neil Kumar, Ph.D., Chief Executive Officer and a member of the board of directors of BBIO, and Frank P. McCormick, Ph.D., F.R.S., D.Sc., Chairman of Oncology and a member of the board of directors of BBIO, were appointed to serve as directors of the Issuer. As a result of their positions, Drs. Kumar and McCormick may, from time to time, engage in discussions with the Issuer's board of directors, management, or other stockholders regarding matters relating to the Issuer's business, operations, governance, strategy, or capital structure. These discussions may include, but are not limited to: (i) the acquisition or dispos… Full filing
17.5% new 13.9m≈ $105.8m 2025-08-18
BlackRock Portfolio Management LLC 13G · institution new · filed 2025-04-15 7.9% new 1.5m 2025-04-15
Flynn James E 13G · passive investor new · filed 2025-08-18 6.2% new 4.9m≈ $37.2m 2025-08-18
BC Global Opportunities IX LP 13G · passive investor new · filed 2025-09-03 5.5% new 4.4m≈ $33.3m 2025-09-03

Insider purchases and sales in Q4 2025

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q1 24: 1 buyingQ1 24: 0 sellingQ2 24: 0 buyingQ2 24: 0 sellingQ2 24Q3 24: 0 buyingQ3 24: 0 sellingQ4 24: 0 buyingQ4 24: 0 sellingQ4 24Q1 25: 0 buyingQ1 25: 0 sellingQ2 25: 0 buyingQ2 25: 0 sellingQ2 25Q3 25: 0 buyingQ3 25: 0 sellingQ4 25: 0 buyingQ4 25: 0 sellingQ4 25
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q1 20241$24.0m0——
Q2 20240—0——
Q3 20240—0——
Q4 20240—0——
Q1 20250—0——
Q2 20250—0——
Q3 20250—0——
Q4 20250—0——

None reported in Q4 2025.

Holders, Q4 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Cormorant Asset Management, LP 12.69% of their portfolio BOSTON, MA 17,878,59417.9m $223.8m $223.8m 12.69% Unchanged
2 DEERFIELD MANAGEMENT COMPANY, L.P. 0.78% of their portfolio New York, NY 4,885,4464.9m $61.2m $61.2m 0.78% Unchanged
3 Omega Fund Management, LLC 14.37% of their portfolio Boston, MA 3,289,6613.3m $41.2m $41.2m 14.37% Unchanged
4 WELLINGTON MANAGEMENT GROUP LLP 0.01% of their portfolio Boston, MA 2,907,0032.9m $36.4m $36.4m 0.01% Reduced -54.3k -54,260
5 EcoR1 Capital, LLC 1.61% of their portfolio San Francisco, CA 2,823,1262.8m $35.3m $35.3m 1.61% Unchanged
6 Alphabet Inc. 1.37% of their portfolio Mountain View, CA 2,823,1262.8m $35.3m $35.3m 1.37% Unchanged
7 ENAVATE SCIENCES GP, LLC 6.49% of their portfolio New York, NY 2,626,9462.6m $32.9m $32.9m 6.49% Unchanged
8 CITADEL ADVISORS LLC 0.02% of their portfolio MIAMI, FL 2,530,3242.5m $31.7m $31.7m 0.02% Reduced -7.8k -7,817
9 Paradigm Biocapital Advisors LP 0.76% of their portfolio NEW YORK, NY 2,261,7492.3m $28.3m $28.3m 0.76% Added +395.6k +395,608
10 BlackRock, Inc. 0.00% of their portfolio New York, NY 2,084,8372.1m $26.1m $26.1m 0.00% Added +36.3k +36,285
11 NOVO HOLDINGS A/S 1.91% of their portfolio HELLERUP, G7 1,961,3172.0m $24.6m $24.6m 1.91% Unchanged
12 Laurion Capital Management LP 1.25% of their portfolio NEW YORK, NY 1,464,9381.5m $18.3m $18.3m 1.25% Added +419.1k +419,138
13 ADAGE CAPITAL PARTNERS GP, L.L.C. 0.03% of their portfolio Boston, MA 1,400,0001.4m $17.5m $17.5m 0.03% Reduced -87.6k -87,621
14 EVENTIDE ASSET MANAGEMENT, LLC 0.21% of their portfolio Boston, MA 1,082,3621.1m $13.4m $13.4m 0.21% Unchanged
15 Octagon Capital Advisors LP 1.63% of their portfolio NEW YORK, NY 1,043,1101.0m $13.1m $13.1m 1.63% Unchanged
16 ARMISTICE CAPITAL, LLC 0.31% of their portfolio NEW YORK, NY 1,000,0001.0m $12.5m $12.5m 0.31% Added +588.0k +588,000
17 PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio BALTIMORE, MD 803,134803.1k $10.1m $10.1m 0.00% Reduced -81.9k -81,908
18 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 791,095791.1k $9.9m $9.9m 0.00% Added +143.5k +143,496
19 Aisling Capital Management LP 1.48% of their portfolio NEW YORK, NY 564,625564.6k $7.1m $7.1m 1.48% Unchanged
20 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 561,987562.0k $7.0m $7.0m 0.00% Added +20.4k +20,385
21 Catalio Capital Management, LP 5.55% of their portfolio NEW YORK, NY 410,700410.7k $31.4m $31.4m 5.55% New
22 Casdin Capital, LLC 0.22% of their portfolio New York, NY 282,312282.3k $3.5m $3.5m 0.22% Unchanged
23 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio SAN FRANCISCO, CA 279,046279.0k $3.5m $3.5m 0.00% Reduced -304 -304
24 MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio NEW YORK, NY 241,415241.4k $3.0m $3.0m 0.00% Reduced -128.1k -128,148
25 FMR LLC 0.00% of their portfolio BOSTON, MA 240,300240.3k $3.0m $3.0m 0.00% Added +78.2k +78,223
26 HighVista Strategies LLC 0.74% of their portfolio BOSTON, MA 229,263229.3k $2.9m $2.9m 0.74% New
27 ADAR1 Capital Management, LLC 0.21% of their portfolio AUSTIN, TX 226,248226.2k $2.8m $2.8m 0.21% Reduced -275.0k -274,980
28 Ikarian Capital, LLC 0.36% of their portfolio DALLAS, TX 220,231220.2k $2.8m $2.8m 0.36% Reduced -25.0k -25,000
29 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 218,278218.3k $2.7m $2.7m 0.00% Added +41.6k +41,583
30 Sio Capital Management, LLC 0.27% of their portfolio NEW YORK, NY 130,628130.6k $1.6m $1.6m 0.27% Unchanged
31 TD Asset Management Inc 0.00% of their portfolio Toronto, A6 117,150117.2k $1.5m $1.5m 0.00% Reduced -12.9k -12,912
32 Woodline Partners LP 0.01% of their portfolio San Francisco, CA 103,707103.7k $1.3m $1.3m 0.01% Unchanged
33 MOORE CAPITAL MANAGEMENT, LP 0.03% of their portfolio NEW YORK, NY 100,000100.0k $1.3m $1.3m 0.03% Unchanged
34 GOLDMAN SACHS GROUP INC 0.00% of their portfolio NEW YORK, NY 94,65194.7k $1.2m $1.2m 0.00% New
35 UBS Group AG 0.00% of their portfolio ZURICH, V8 93,36993.4k $1.2m $1.2m 0.00% Added +41.1k +41,143
36 STEMPOINT CAPITAL LP 0.19% of their portfolio NEW YORK, NY 86,51786.5k $1.1m $1.1m 0.19% Reduced -100.1k -100,097
37 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 74,30074.3k $930.2k $930.2k 0.00% New
38 BOOTHBAY FUND MANAGEMENT, LLC 0.02% of their portfolio NEW YORK, NY 67,03467.0k $839.3k $839.3k 0.02% Reduced -29.5k -29,517
39 NORTHERN TRUST CORP 0.00% of their portfolio CHICAGO, IL 58,03458.0k $726.6k $726.6k 0.00% Reduced -37.9k -37,923
40 MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio Toronto, A6 54,19254.2k $670.4k $670.4k 0.00% New
41 Qube Research & Technologies Ltd 0.00% of their portfolio LONDON, X0 35,95236.0k $450.1k $450.1k 0.00% New
42 XTX Topco Ltd 0.01% of their portfolio LONDON, X0 28,63328.6k $358.5k $358.5k 0.01% Added +5.2k +5,249
43 BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio PARIS, I0 26,47226.5k $331.4k $331.4k 0.00% New
44 BIT Capital GmbH 0.01% of their portfolio BERLIN, 2M 25,00025.0k $313.0k $313.0k 0.01% New
45 Point72 Asset Management, L.P. 0.00% of their portfolio STAMFORD, CT 23,58423.6k $295.3k $295.3k 0.00% New
46 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 14,35214.4k $179.7k $179.7k 0.00% Added +13.5k +13,491
47 Quadrature Capital Ltd 0.00% of their portfolio LONDON, X0 12,92212.9k $161.8k $161.8k 0.00% New
48 Squarepoint Ops LLC 0.00% of their portfolio NEW YORK, NY 11,51511.5k $144.2k $144.2k 0.00% New
49 Persistent Asset Partners Ltd 0.05% of their portfolio HONG KONG, K3 8,5858.6k $107.5k $107.5k 0.05% New
50 CIBC Private Wealth Group LLC 0.00% of their portfolio ATLANTA, GA 5,0005.0k $62.6k $62.6k 0.00% New
51 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 3,9904.0k $50.0k $50.0k 0.00% Added +2.7k +2,661
52 Rockefeller Capital Management L.P. 0.00% of their portfolio NEW YORK, NY 700700 $8.8k $8.8k 0.00% New
53 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 300300 $3.8k $3.8k 0.00% New